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ABSTItACT
Preflight data from 64 first-time Shuttle crew-
members were examined retrospectively to predict
space sickness severity (NONE, MILD, MODERATE, or
SEVERE) by discriminant analysis. From nine
input variables relating to fluid, electrolyte,
and cardiovascular status, eight variables were
chosen by discriminant analysis that correctly
redicted space sickness severity with 59% success
y one method of cross-validation on the original
sample and 67% by another method. The eight
variables in order of their importance for pre-
dicting space sickness severity are sitting
systolic blood pressure, serum uric acid, calcu-
lated blood volume, serum phosphate, urine
osmolality, environmental temperature at the
launch site, red cell count, and serum chloride.
These results suggest the presence of predisposing
physiologic factors to space sickness that
implicate a fluid shift etiology. Addition of a
tenth input variable, hours spent in the
Weightless Environment Training Facility (WETF),
improved the prediction of space sickness severity
to 66% success by the first method of cross-
validation on the original sample and to 71% by
the second method. The data suggest that WETF
training may reduce space SicKness severity.
Astronauts while in WETF training are not oriented
by gravity but remain physiologically susceptible
to it, causing cephalad shifts of fluid when they
are head down. As a result, they may physiologic-
ally adapt to the fluid shifts by reducing their
blood volume, which also occurs in weightlessness.
If fluid shifts contribute to space sickness,
readaptation of the circulation by preflight
lood volume reduction may counteract fluid
shifts in weightlessness and help to alleviate
space sickness.
INTRODUCTION
Space sickness is an operationally significant
problem that occurs to varying degrees of severity
in about two-thirds of Shuttle astronauts (Davis
et al., 1988). Besides being a nuisance, mission
performance can be negatively impacted when
astronauts are severely space sick, and safety is
an important issue. An emergency Shuttle landing
early in a mission could be endangered if the
pilot and commander were spacesick (Vanderploeg et
al., 1985). The risk of fatality from vomiting in
a spacesuit is presently minimized by an opera-
tional policy prohibiting extravehicular activity
(EVA) during the first three mission days when
space sickness is most likely to occur. Space
sickness typically begins about an hour after
orbital insertion, reaches a peak within 24 to 48
hours, and usually resolves between 30 to 48
hours, although it can persist for 72 hours. The
time course is variable, however, with occasional
delayed-onset space sickness occurring after two
days in space (Thornton et al., 1987). NASA has
expended great effort in attempting to understand,
predict, and treat space sickness to relieve crew
discomfort, increase mission productivity, and
enhance safety.
Space sickness did not occur in the early days of
spaceflight; apparently the larger cabins in
Apollo and later spacecraft permitted enough
mobility to exceed vestibular susceptibility
thresholds for the induction of space sickness.
However, susceptibility to vestibular stimulation
is not likely to be the sole etiologic factor in
space sickness, because preflight tests of
astronauts' motion sickness susceptibilities do
not correlate significantly with space sickness
and are not useful for prediction (Homick et al,
1987). Although the dominant paradigm at this
time regards the space sickness problem as a form
of motion sickness resulting from novel
neurovestibular stimulation in the unique
environment of weightlessness (Crampton, 1990), it
may be more Fruitful to consider space sickness as
a binary process. While the dominant paradigm is
probably correct in that an essential component of
space sickness involves some unaccustomed neuro-
vestibular stimulation, a second important factor
may be a decreased threshold of susceptibility to
nauseogenic stimuli in general, brought on by
physiologic responses to weightlessness. Among
the insults upon homeostasis in the early hours
and days of a mission which might lower an
astronaut's tolerance to provocative vestibular
stimuli are some of the effects of fluid shifts.
There is believed to be a dramatic headward fluid
redistribution with substantial physiologic re-
sponses immediately upon exposure to weightless-
ness (Greenleaf, 1984). This simple picture is
complicated somewhat by the Fact that fluid shifts
probably begin while astronauts wait in the semi-
supine position before launch (Lathers, 1989).
Regardless, space sickness follows closely upon
the time course of both these fluid shifts and
the major physiological perturbations they
roduce. Fluid shifts caused by head-down tilt in
edrest studies sometimes are associated with
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dizziness and nausea upon head movement, spontan-
eous nystagmus, and vestibular illusions of tilt-
ing and falling (Kakurin et al, 1975). Fluid
shifts caused by water immersion have been report-
ed to increase vestibular susceptibility to calor-
ic stimulation so much that sometimes the caloric
stimulation had to be stopped (Mitarai et al,
1981).
Several potential mechanisms exist by which fluid
shifts may contribute to space sickness, whether
or not the fluid shifts bevin on the launch pad
(Simanonok et al., in review). We have previously
shown that nine preflight variables relating to
fluid, electrolyte, and cardiovascular status can
be used to predict space sickness incidence with
about 80% success and space sickness severity with
55% success using two methods of "pseudo" cross-
validation on the original sample of 64 subjects
(Simanonok et al., in review). In the present
study, the same nine predictor variables have been
used, with the addition of the astronauts'
training time in the Weightless Environment
Training Facility (WETF) as a potential predictor
of space sickness. This variable was added
because Youmans et al. (1987) have reported an
inverse relationship between WETF training and
space sickness severity.
The WETF is a tank of water measuring 33 by 78
feet and 25 feet deep. It is used to simulate
weightlessness for astronauts preparing for EVA;
not all astronauts get WETF training. Astronauts
who train in the WETF wear full space suits
adjusted for neutral buoyancy in the water. Suit
pressure is regulated to approximately 4.2 PSI
above the water pressure at any given depth, so
there is no externally applied hydrostatic
gradient on their bodies as occurs in most water
immersion studies. However, they are still in a
gravity field and they may sometimes assume head-
down positions, which would cause headward fluid
shifts to occur. It is possible that repeated
exposure to fluid shifts in WETF training confers
some preflight physiologic adaptation to the
astronauts which lessens their physiologic respon-
ses to fluid shifts in weightlessness, therefore
helping to protect against space sickness if
fluid shifts are involved in space sickness
etiology. An alternative or adjunct hypothesis is
that unusual positional orientations that the
astronauts assume relative to the spacecraft
mockups in WETF training help to visually adapt
them to similar orientations they will experience
in weightlessness. Visual adaptation might reduce
the impact of the "sensory conflict" conceptions
of the dominant paradigm (Crampton, 1990) that may
also be an important component of space sickness.
METHODS
Preflight clinical data for 64 first-time Shuttle
crewmembers were used in this study. Not all
measures were available at the same times
preflight, and some measures were made several
times preflight. The first available data for
each crewmember were used in this order: launch
minus 30 days, launch minus 10 days, and launch
minus 3 or 2 days. Variables not measured for a
given astronaut on any of those occasions were
obtained from their annual physicals. Each
astronaut's space sickness severity was determined
by a NASA flight surgeon according to the ordinal
scale shown in Table I. Space sickness incidence
was defined as any occurrence of space sickness
from MILD through SEVERE and called SICK, as
opposed to the NONE category. However, the
prediction of space sickness incidence was not
improved by addition of WETF training over the 80%
success obtained by the nine fluid shift variables
alone (Simanonok et al., in review), so those
results are not reported here. Space sickness
severity was defined as the degree of space
sickness from NONE through SEVERE. Predicted
preflight blood volumes for each astronaut were
calculated on the basis of sex, height and weight
by the method of Feldschuh and Enson (]977). Free
air maximum and minimum temperatures for three
days before each Shuttle launch plus launch day at
the Shuttle Landing Facility at Kennedy Space
Center were obtained from the Landing Support
Office at the Johnson Space Center. Means of the
minimum four-day temperatures were used in the
following analyses as the prediction variable
representing environmental temperature at the
launch site. The WETF training data we used are a
subset of those previously analyzed and reported
by Youmans et al. (1987) because we did not have
available the other prediction variables for some
of the astronauts in their larger WETF sample.
TABLE ]
SPACE SICKNESS SCORING CRITERIA
From Davis et al. (]988)
NONEre(o)
NO SIGNS OR SYMPTOMS REPORTED WITH THE
EXCEPTION OF MILD TRANSIENT HEADACHE OR MILD
DECREASED APPETITE.
MILD (i)
ONE TO SEVERAL SYMPTOMS OF A MILD NATURE; MAY
BE TRANSIENT AND ONLY BROUGHT ON AS THE
RESULT OF HEAD MOVEMENTS; NO OPERATIONAL
IMPACT; MAY INCLUDE SINGLE EPISODE OF
RETCHING OR VOMITING; ALL SYMPTOMS RESOLVED
IN 36-48 HOURS.
MODERATE (2)
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT
NATURE THAT MAY WAX AND WANE; LOSS OF
APPETITE; GENERAL MALAISE, LETHARGY AND
EPIGASTRIC DISCOMFORT MAY BE MOST DOMINANT
SYMPTOMS; INCLUDES NO MORE THAN TWO EPISODES
OF VOMITING; MINIMAL OPERATIONAL IMPACT, ALL
SYMPTOMS RESOLVED IN 72 HOURS.
SEVERE (3)
SEVERAL SYMPTOMS OF A RELATIVELY PERSISTENT
NATURE THAT MAY WAX AND WANE; IN ADDITION TO
LOSS OF APPETITE AND STOMACH DISCOMFORT,
MALAISE AND/OR LETHARGY ARE PRONOUNCED;
STRONG DESIRE NOT TO MOVE HEAD; INCLUDES MORE
THAN TWO EPISODES OF VOMITING; SIGNIFICANT
PERFORMANCE DECREMENT MAY BE APPARENT;
SYMPTOMS MAY PERSIST BEYOND 72 HOURS.
Statistical analyses were performed with BMDP
(BMDP Statistical Software, Inc., Los Angeles, CA)
on either a Digital Equipment Corporation (West-
minster, MA) VAX 780 or VAX 3400. Prediction of
space sickness severity was performed in this
study by discriminant analysis. Chi-square
analyses were done to provide a comparison of the
prediction success expected due to chance alone
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and to estimate the significance level of WETF
training on reducing space sickness severity as
compared to that which would be expected to occur
by chance. Spearman correlation coefficients were
done to describe the strengths of relationships
among the prediction variables and between the
prediction variables and the criterion. Mann-
Whitney rank-sum tests were used to test for
differences between variables in each of the space
sickness groups with their counterparts in the
NONE group, and between the two groupings of
astronauts that either did or did not receive WETF
training. Statistical significance was accepted
at p<O.05.
Data Analysis
The discriminant analysis program calculated an
analysis of variance in a series of steps,
selecting one variable at each step with the
greatest F value. A classification function was
then derived which reduced the prediction
variables into a single weighted composite with
appropriate weighting coefficients for separation
of the cases into the groups that they belonged.
A similar application of discriminant analyses
with a more extensive description of rationale and
procedures can be found in Reschke et al. (]984).
Our previous analyses were performed with nine
preflght variables describing some aspects of
fluid, electrolyte, and cardiovascular status
(Simanonok et al., in review). In that work we
initially compared the efficacy of the same nine
variables in predicting several different group-
ings of space sickness incidence and severity, so
the same nine variables were used in all cases;
i.e., they were "forced" into the discriminant
analyses rather than being chosen by the program.
In this work we removed the force instruction and
allowed the program to choose the variables which
best predicted the criterion variable, space
sickness score. Variable selection was limited
by setting the minimum F-to-enter at 1.5, which
provided an approximate F-value in terms of con-
tributing to the predictions at the end of
variable selection that was statistically
significant at p<O.05.
Two estimates were calculated of the ability of
the nine fluid shift variables to predict space
sickness severity on an ideal hypothetical cross-
validation sample composed of new cases. One
type of cross-validation on the original sample
termed a "jackknife" cross-validation was cal-
culated, in which each case was removed from the
analysis one at a time and new weighting coeffic-
ients on the classification functions (keeping
the same variables) were computed with the
remaining 63 cases. The new classification func-
tion was then used to classify each case as it was
removed. Second, a subsample cross-validation was
performed. Arbitrarily, 40 cases were selected by
stratified random sampling and used to create
classification functions to predict the remaining
24 cases. In this second method of cross-
validation the variables originally chosen as
predictors were forced into discriminant analyses
to allow an evaluation of their success in
predicting space sickness by this cross-validation
method.
RESULTS
The nine fluid shift variables used as input in
discriminant analyses are shown in relation to
space sickness scores in Fig. 1. A similar plot
of the relationship between WETF training time and
space sickness severity is shown in Figure 2.
Figure 3 depicts the WETF data in a different
form, showing the number of astronauts in each
space sickness category that did and did not have
WETF training, regardless of the number of hours
spent. Intercorrelations of the nine original
predictor variables, WETF training time, and space
sickness severity are shown in Table 2.
Prediction of space sickness severity using nine
fluid shift variables as input is shown in Table
4. The program chose eight variables as
predictors and used them to create classification
functions which could classify the 64 astronauts
into the correct space sickness category with 69%
success. The eight variables were chosen in this
order: sitting systolic blood pressure, serum uric
acid, calculated blood volume, serum phosphate,
urine osmolality, environmental temperature at the
launch site, red cell count, and serum chloride.
The jackknife cross-validation success of 59% pre-
diction shows some shrinkage from the classifica-
tion matrix, a typical phenomenon for cross-
validation studies. The results of jackknife
cross-validation may best reflect the true proba-
bility of correctly predicting new cases of space
sickness on the basis of the 64 subjects used
in this study. The subsample cross-validation
success rate of 67% is more likely to be artifact-
ually high due to chance, because only data from
40 subjects were used to predict space sickness
severity in the remaining 24 subjects.
Addition of WETF training time as a tenth variable
in another set of discriminant analyses improved
the prediction of space sickness severity, shown
in Table 5. The program again chose eight of the
ten variables as significant predictors of space
sickness, this time forming classification
functions that separated the 64 astronauts into
their correct space sickness category with 77%
success. The eight variables were chosen in this
order: WETF training time, sitting systolic blood
pressure, serum uric acid, calculated blood
volume, serum phosphate, urine osmolality, envi-
ronmental temperature at the launch site, and red
cell count; serum chloride fell out from the
earlier prediction. The jackknife cross-validation
success was improved to 66%, and the subsample
cross-validation to 71%.
For comparison, the percent success in predicting
space sickness severity that would result from
chance alone is 32%, as shown in Table 3. This
table was computed by chi-square anal#sis, but the
expected values in some cells are less than I,
violating the necessary assumptions for probabil-
istic comparisons with the above predictions of
space sickness severity with and without WETF
training. Combining the MODERATE and SEVERE
groups to increase the expected values enabled
valid chi-square comparisons for the classifica-
tion and jackknife matrixes but not the subsample
matrixes; for both those sets of predictions with
and without WETF training, the predictions are
significantly better than chance at p < 0.00005.
When WETF training time was used as the sole input
variable for discriminant analysis to predict
space sickness severity, the prediction successes
obtained by the classification functions and by
jackknife cross-validation were both 42%. The
subsample cross-validation showed 33% success, the
same expected due to chance.
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Finally, the 64 astronauts were split into two
groups according to whether they had WETF training
(n = 36) or not (n = 28). Mann-Whitney tests
between these two groups were performed on the
nine fluid shift variables and 46 other clinical
and anthropometric variables, some derived by
calculation, available for this sample of
astronauts. Of interest are these differences
(mean ± SEM) found in serum chloride, WETF =
104.25 ± 0.41 mEq/L, no WETF = 105.86 ± 0.42 mEq/L
(p = 0.0]53); plasma osmolality, WETF = 289.53 ±
0.62 mOsm/kg, no WETF = 292.2] ± 0.63 mOsm/kg (p =
0.0052); urine specific gravity, WETF = 1.0192 +
O.OOI], no WETF = 1.0162 ± 0.00]2; and forced
vital capacity indexed to body weight, WETF :
0.0660 + 0.0018 L/kg (n = 35), no WETF = 0.0604 +
0.0019 LTkg (n = 27), (p = .0400). These were the
only variables found to differ between WETF
trained and untrained astronauts at p<O.05.
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FIG. 1. NINE PREFLIGHT VARIABLES USED TO PREDICT SPACE SICKNESS.
Individual points are plotted in ascending order within each space sickness group at arbitrary but
equidistant points along the x-axis for evaluation of the raw data. Black squares are means (± S.D.)
for each group plotted at the median position in the range of points. P values are from Mann-Whitney
significance tests of the three sick groups separately tested against the NONE group.
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FIG. 2 HOURS IN WETF TRAINING VERSUS SPACE
SICKNESS SEVERITY.
* The MILD group had significantly more training
hours than all of the other groups by a
Mann-Whitney test at p<O.05. Black squares are
means (± S.D.).
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FIG. 3. PRESENCE AND ABSENCE OF WETF TRAINING
RELATIVE TO SPACE SICKNESS SEVERITY.
When the MODERATE and SEVERE groups were combined
to enable a valid chi-square test, the differences
in space sickness severity due to WETF training
were significantly different from chance at p =
0.0067.
TABLE 2. SPEARMAN CORRELATIONS AMONG THE ORIGINAL
NINE PREDICTION VARIABLES RELATED TO FLUID,
ELECTROLYTE, OR CARDIOVASCULAR STATUS; INCLUDED
ARE WETF TRAINING HOURS AND SPACE SICKNESS SCORES.
SCORE URICAC THT4 CL RBC MINT p04 UROS BV S]TSYS
TABLE 3. PREDICTION SUCCESS FOR SPACE SICKNESS
SEVERITY THAT WOULD BE EXPECTED SOLELY DUE TO
CHANCE (determined by chi-square).
PREDICTED
PERCENT
CHANCE CORRECT NONE MILD MODERATE SEVERE
URICAC -.32" 1
THT4 .32" -.17 1
CL .27" -.08 .29" I
RBC .26" .25" .18 -.02 1
MINT .25" -.07 .06 .14 -.20 I
p04 -.25" -.05 .03 -.21 -.12 .10 I
NONE 47% 12.7 7.2 5.9 1.3
MILD 26% 8.9 5.0 4.2 0.9
MODERATE 21% 6.1 3.5 2.8 0.6
SEVERE 4% 2.3 1.3 1.1 0.2
TOTAL 32% 30 17 14 3
UROS .24 .00 .17 .01 .21 .12 -.13 I
BV .23 .14 .20 -.05 .28" .16 -.11 .27* 1
SITSYS .14 .17 -.09 -.14 .33" -.11 -.10 .17 .11 1
WETF -.17 .04 -.06 -.28" .01 -.17 .05 .11 -.07 -.02
* p < 0.05. All pairs are n : 64. SCORE =
space sickness score; URICAC = serum uric acid;
THT4 = serum thyroxine; CL = serum chloride; RBC =
red cell count; MINT = minimum free air tempera-
ture at the launch site; P04 = serum phosphate;
UROS = urine osmolality; BV = predicted blood
volume; SITSYS = sitting systolic blood pressure;
WETF = hours of WETF training.
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TABLE 4
PREDICTION OF SPACE SICKNESS SEVERITY USING NINE VARIABLES RELATED TO FLUID, ELECTROLYTE, AND
CARDIOVASCULAR STATUS SHOWN IN FIGURE I
I. MEANS AND STANDARD DEVIATIONS OF VARIABLES USED
GROUP =
VARIABLE
BV 5191 5449
ml 509 524
MINT 59.8 63.0
deg. F 12.6 11.3
THT4* 7.20 7.73
_g/dL 1.25 1.43
RBC 4.72 4.91
1012/L .36 .44
SITSYS 118 122
mmHg 8 10
UROS 536 706
mOsm/kg 241 234
PO4 3.29 3.05
mg/dL .52 .49
CL i05 104
mEq/L 2 3
URICAC 5.97 5.06
mg/dL 1.53 1.02
n 27 19
* THT4 was provided as input but not
discriminant analysis program
Ill. CLASSIFICATION MATRIX
NONE MILD MODERATE SEVERE PREDICTED
II. CLASSIFICATION FUNCTIONS
PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
5223 5770
620 242 NONE 85% 23 3 I 0
67.5 65.9 MILD 68% 4 13 2 0
6.0 8.4
MODERATE 39% i 7 5 0
8.16 8.20
1.38 .71 SEVERE 60% 0 I I 3
4.85 5.09 TOTAL 69% 28 24 9 3
.39 .44
117 130
10 12 IV. JACKKNIFE CROSS-VALIDATION MATRIX
692 574 PREDICTED
218 215 PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
3.15 2.72
.47 .44
NONE 81% 22 3 2 0
106 107
3 i MILD 58% 5 iI 3 0
4.86 5.32 MODERATE 23% 2 8 3 0
i .35 .80
SEVERE 40% 0 2 I 2
13 5
TOTAL 59% 29 24 9 2
chosen by the
GROUP = NONE MILD MOOERATE SEVERE
VARIABLE
BV 0.02517 0.02621 0.02502 0.02804
MINT 0.96085 1.05467 1.10696 1.10827
RBC 29.40623 32.22703 33.21688 33,39625
SITSYS 1.97799 2,03264 1.97129 2,15279
UROS -0.01940 -0.01654 -0.01594 -0.020/6
P04 31.37756 29.48028 29.95746 28.24583
CL 21.55503 21.49715 21.71196 22.00787
URICAC -2,07219 -3.45289 -3.40062 -3.82808
CONSTANT -1448,37415 -1462.26501 -1481.95349 -1544.08777
V. SUBSAMPLE CROSS VALIDATION ON 24 CASES NOT USED
IN CALCULATION OF THE CLASSIFICATION FUNCTION
PREDICTED
PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
NONE 100% 10 0 0 0
MILD 57% 2 4 0 I
MODERATE 20% 0 4 i 0
SEVERE 50% 0 I 0 I
TOTAL 67% 12 9 ] 2
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TABLE 5
PREDICTION OF SPACE SICKNESS SEVERITY USING NINE VARIABLES RELATED TO FLUID, ELECTROLYTE, AND
CARDIOVASCULAR STATUS SHOWN IN FIGURE 1, WITH WETF TRAINING TIME ADDED
I. MEANS AND STANDARD DEVIATIONS OF VARIABLES USED
GROUP =
VARIABLE
BV
ml
MINT
deg. F
THT4*
#g/dL
RBC
lOI2/L
SITSYS
mmHg
UROS
mOsm/kg
P04
mg/dL
CL*
mEq/L
URICAC
mg/dL
WETF
hrs
Ill. CLASSIFICATION MATRIX
NONE MILD MODERATE SEVERE PREDICTED
519] 5449 5223 5770
509 524 620 242
59.8 63.0 67.5 65.9
12.6 11.3 6.0 8.4
7.20 7.73 8.16 8.20
1.25 ].43 1.38 .71
4.72 4.91 4.85 5.09
.36 .44 .39 .44
]18 122 ]]7 130
8 10 10 12
536 706 692 574
241 234 218 215
3.29 3.05 3.15 2.72
.52 .49 .47 .44
105 104 106 107
2 3 3 I
5.97 5.06 4.86 5.32
1.53 1.02 1.35 .80
27.67 55.10 11.77 10.00
26.41 42.16 ]9.32 22.36
n 27 19 13 5
* THT4 and CL were provided as input but not
chosen by the discriminant analysis program
II. CLASSIFICATION FUNCTIONS
GROUP = NONE MILD MOOERATE SEVERE
VARIABLE
BV 0.01556 1.11410 1.15981 1.16245
MINT 1.01556 1.11410 1.15981 1.16245
RBC 33.38202 36.10495 37.26220 37.48561
SITSYS 1.32721 1.39953 1.30835 1.482B4
UROS -0.00915 *0.00660 -0.00547 -0.01019
P04 8.93290 7.10558 7.34489 5.32631
URICAC -4.14167 -5.60553 -5.44387 -5.91047
WE_F 0.08596 0.11994 0.07066 0.07598
CONSTANT -222.64264 -246.32925 -237.16216 *265.42923
I
PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
NONE 89% 24 2 1 0
MILD 63% 5 12 2 0
MODERATE 77% 1 2 10 0
SEVERE 60% O I I 3
TOTAL 77% 30 17 14 3
IV. JACKKNIFE CROSS-VALIDATION MATRIX
PREDICTED
PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
NONE 81% 22 2 3 0
MILD 58% 5 ]i 2 I
MODERATE 54% 3 3 7 0
SEVERE 40% 0 1 2 2
TOTAL 66% 30 17 14 3
V. SUBSAMPLE CROSS VALIDATION ON 24 CASES NOT USED
IN CALCULATION OF THE CLASSIFICATION FUNCTION
PREDICTED
PERCENT
ACTUAL CORRECT NONE MILD MODERATE SEVERE
NONE 200% lO 0 0 0
MILD 57% 2 4 0 i
MODERATE 40% 0 2 2 I
SEVERE 50% 0 1 0 i
TOTAL 71% 12 7 2 3
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DISCUSSION
The validity of any prediction is limited by the
reliability of the predictors and of the criterion
variable, in this case space sickness score
!Calkins et al., 1987). The possibility of errors
in the predictor variables and the criterion
should be recognized. Space sickness scores were
evaluated by various flight surgeons over five
years, based on medical debriefs from 64
individuals with varying subjective symptoms, many
of whom were medicated in attempts to reduce the
severity of their space sickness. It is possible
that anti-motion sickness medication (primarily
scopolamine-dextroamphetamine) may have reduced
symptom severity in enough astronauts to bias the
space sickness scores. However, because space
sickness usually recurs in the same astronauts in
subsequent flights (although there is a tendency
for symptoms to lessen on a second flight), it is
generally believed that space sickness scores are
sufficiently reliable to be predictable (Calkins
et al., 1987).
The reliability of the predictors probably varies
from one to the next. Because the clinical
variables were measured at different times before
Flight, few of them probably exactly matched the
astronauts' physiologic status on launch day, with
the possible exception of height, which was
measured to the nearest inch, or half-inch in a
few cases. Preflight blood volumes were only
calculated, not measured. The free air tempera-
ture at the launch site is only a rough approxima-
tion of the actual environmental temperatures to
which astronauts may have been exposed. Consider-
ing the potential sources of error in the data,
it should not be surprising that even the best
correlations of the predictor variables with space
sickness are as low as they are. Conversely,
detecting statistically significant relationships
in the midst of noisy data implies the presence of
fairly strong relationships.
Previous analyses (Simanonok et al., in review),
if they hold up on Further cross-validation,
achieved NASA's technical goal of the development
of a risk profile for predicting space sickness
incidence with 80% confidence (Lackner, 1982).
That rate of success in predicting space sickness
severity, however, may await an understanding of
the underlying mechanisms causing space sickness
and improvements in the reliability of predictor
and criterion scores, as has been proposed
(Calkins et al., 1987).
Because the nine fluid shift variables describe
aspects of preflight fluid, electrolyte, and
cardiovascular status, applying them to predict
space sickness with levels of success substantial-
ly better than chance is supportive of a fluid
shift role in space sickness etiology. We cannot
conclude if these predictor variables are markers
for other factors or are somehow themselves
determinants of space sickness, but some of them
seem to present clearer relationships than others
to a potential role of fluid shifts in space
sickness, relationships which can be integrated
into a mechanistic hypothesis for a fluid shift
etiology of space sickness developed previously
(Simanonok et al., in review). To summarize,
the magnitude of an individual's response to
Fluid shifts probably depends on the magnitude of
the fluid shift itself and on the individual's
heart size relative to their blood volume.
People with elevated blood volumes may suffer a
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greater central volume expansion in weightless-
ness, and vice versa. One response to central
volume expansion on earth and in space is the
release of atrial natriuretic peptides (ANP) from
the heart (Epstein et al., 1987; Gharib et al.,
1986; Leach et al., 1988). Mountain sickness may
in some respects resemble space sickness because
it is associated with central volume expansion and
elevated plasma ANP (B_rtsch et al, 1991). And
infusion of ANP at high doses into human subjects
can cause nausea without any provocative motion
stimulus at all (Weidmann et al., 1986). There-
fore it is plausible that space sickness could
result in part from a lowering of the threshold
for nausea induction by ANP released in weight-
lessness in a dose-dependent fashion relative to
individual responses to fluid shifts.
It is consistent with this fluid shift hypothesis
of space sickness etiology that factors which
modify the blood volume upward or downward might
affect the volume of the fluid shift in weight-
lessness and subsequent physiologic responses. A
variety of factors may modify the blood volume,
some of which emerged previously among the nine
predictor variables for space sickness (Simanonok
et al, in review). In water immersion studies and
head-down tilt as well as in weightlessness there
is observed a contraction of the blood volume.
It may be that with intermittent exposure to
head-down tilt in WETF training, astronaut's blood
volumes are reduced somewhat so that their subse-
quent fluid shifts in weightlessness are lessened
in magnitude, hence their physiologic responses
to Fluid shifts are damped. WETF training may
therefore be effective in ameliorating space
sickness severity by partially preadapting the
circulation to fluid shifts through a reduction of
blood volume.
Alternatively or in addition, WETF training may be
protective against space sickness because of the
visual adaptation that it might provide. In WETF
training, astronauts can assume almost any
orientation with the spacecraft mockups. This
could help to accustom them to the visual
orientations of the spacecraft that they exper-
ience in space, thereby reducing their sensitivity
to the "sensory conflict" that presently forms
the dominant paradigm of space sickness etiology
(Crampton, 1990).
The present data cannot be used to conclusively
determine which of these two potential mechanisms
of WETF training, preadaptation of the blood
volume to fluid shifts or visual adaptation to
weightless surroundings, plays the single or domi-
nant role in ameliorating space sickness severity.
However, the fact that the WETF trained group of
astronauts had significantly lower serum chlorides
and plasma osmolalities, and higher urine specific
gravities and forced vital capacity indexes is
consistent with probable effects of WETF training
on fluid balance. There was also a low but sig-
nificant inverse correlation between WETF
training time and serum chloride concentration
(Table 2). Lower serum chlorides and plasma
osmolalities in WETF trained astronauts could
indicate a state of partial recovery from fluid
shifts, in which fluid and electrolyte losses
caused by fluid shifts in WETF training were
partially restored by drinking but electrolyte
restoration lagged. Higher urine specific grav-
ities in WETF trained astronauts would suggest
renal states of fluid retention, increased elec-
trolyte excretion, or thirst inhibition, any of
whichmight result from fluid shifts in WETFtraining dependingonthe timingof thetraining
and the sampling. Forcedvital capacity isgreaterin humansubjects whenstandingcomparedto supine (Dikshit andPatrick, ]986)andafterbedrest of ]1 or 12days(Beckettet al., 1986).
This suggeststhat a decreasedcentral blood
volumeallows greater lung capacities due to
posturalfluid shifts, after adaptationto fluid
shifts in bedrest, andafter adaptationto fluid
shifts in WETFtrainedindividuals.
Althoughmechanismsremainspeculative,thedata
suggestthat WETFtraining maybe a partially
effectivemethodto reducethe severity of space
sicknessfor astronauts. If WETFtraining is
effective in amelioratingspacesicknessthrough
visual adaptation, its role couldbe expandedso
that all astronauts,or perhapsthose whoarepredictedmost likely to Decomespacesick, getWETFtraining. If WETFtraining is shownto be
beneficialas a countermeasureto spacesicknessbyreducingthe preflight bloodvolumeandthereby
diminishingthe physiologic effects of fluid
shifts in weightlessness,othermoredirect inter-
ventionsto preadaptthe circulation to fluid
shifts maybeevenmoreeffective.
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